Verge Medical, a privately held medical technology company focused on advancing physician-driven solutions to address persistent gaps in vascular care, today announced the acquisition of the RoVo™ System and its patented Temporary Occlusion Embolectomy (TOE) technology from 2MG Medical. The acquisition enhances Verge's expanding portfolio of targeted, setting-specific solutions for coronary and peripheral vascular interventions..

Verge Medical是一家专注于推进由医生驱动的解决方案以解决血管护理中持续存在的差距的私人医疗技术公司，今天宣布从2MG Medical收购RoVo™系统及其获得专利的临时阻塞取栓术（TOE）技术。此次收购增强了Verge在冠状动脉和外周血管介入领域不断扩展的针对性、特定场景解决方案的产品组合。

Distal embolization is a serious complication that commonly occurs during atherectomy and other peripheral interventions. The RoVo System addresses risk of distal embolization with its novel TOE technique, which temporarily blocks downstream blood flow through compression while a vacuum-activated catheter is advanced and rotated to create a patented 'vortex' effect that efficiently captures and removes debris..

远端栓塞是动脉切除术和其他外周介入手术中常见的严重并发症。RoVo系统通过其创新的TOE技术解决了远端栓塞的风险，该技术在通过压迫暂时阻断下游血流的同时，推进并旋转一个真空激活导管，产生一种专利的“涡旋”效应，能够高效捕获并清除碎屑。

The RoVo System exemplifies Verge Medical's mission to provide targeted solutions that are aligned with today's clinical, workflow and reimbursement realities,' stated Mike Buck, CEO of Verge Medical. 'RoVo is a smart, accessible technology designed to empower physicians to manage distal embolization with greater confidence.

“RoVo系统体现了Verge Medical致力于提供与当今临床、工作流程和报销现实相符的针对性解决方案的使命，”Verge Medical首席执行官Mike Buck表示。“RoVo是一项智能且易于获取的技术，旨在帮助医生更加自信地管理远端栓塞。”

We look forward delivering innovative, practical tools like RoVo into the hands of physicians who need them most.'.

我们期待将像RoVo这样创新、实用的工具交到最需要它们的医生手中。

The RoVo System joins the company's expanding portfolio, which includes the FLASH™ Aorto-Ostial Angioplasty System, used in over 25,000 procedures to date, and the Wavella™ specialty infusion catheter for venous therapy.

RoVo系统加入了该公司不断扩展的产品组合，该组合包括迄今已用于超过25,000例手术的FLASH™主动脉口部血管成形术系统，以及用于静脉治疗的Wavella™专用输液导管。

With FDA clearance, the RoVo System and its patented TOE technique reinforce Verge Medical's commitment to advancing vascular care through practical, physician-driven innovation designed to improve safety, efficiency, and outcomes.

凭借FDA的批准，RoVo系统及其获得专利的TOE技术进一步巩固了Verge Medical致力于通过实用的、由医生驱动的创新来提升血管护理的承诺，旨在提高安全性、效率和治疗效果。

About Verge Medical

关于Verge医疗

Based in Campbell, California, Verge Medical is a private medical technology company advancing the future of vascular care through a platform of physician-led innovations. The company's solutions are designed to address persistent gaps in coronary and peripheral interventions, improving procedural efficiency, safety, and patient outcomes.

总部位于加利福尼亚州坎贝尔的Verge Medical是一家私营医疗技术公司，通过医生主导的创新平台推动血管护理的未来。该公司提供的解决方案旨在解决冠状动脉和外周介入领域长期存在的不足，提高手术效率、安全性和患者预后。

Learn more at www.vergemedical.com..

欲了解更多信息，请访问 www.vergemedical.com。

Source: prnewswire.com

来源：prnewswire.com